The Discovery on Target Attendee List is comprised of attendee and inquiries of the Cambridge Healthtech Institute produced conference.
|13,865||Total Universe / Universe Rate||$195.00/M|
|8,709||U.S. Postal Addresses||$195.00/M|
|5,156||Int'l Postal Addresses||$280.00/M|
The Discovery on Target (DOT), is the industry’s preeminent event on novel drug targets and technologies, this show brings together drug discovery professionals annually. This event highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.
The show demonstrates new programming dedicated to PROTACs and their applications, drugs and targets in fibrosis, novel immune-oncology targets, RNA as an emerging target for small molecule drugs, along with expanded coverage of protein engineering and novel biotherapeutics.
This audience is receptive to marketing offers from retailers, email marketers, clinical trials, tradeshow coordinators, industry publications, financial institutions, medical technology, and continuing education providers. Multi-channel marketing is available.
Job Function (20.00/M) Director 1,943 Executive 1,881 Manager 1,209 Professor 2,467 Scientist / Technologist 3,937 Primary Business (20.00/M) Academic 3,779 Biotechnical 4,875 Healthcare Provider 1,115 Pharmaceutical - Big 1,977